Literature DB >> 2405290

HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study.

O A Selnes1, E Miller, J McArthur, B Gordon, A Muñoz, K Sheridan, R Fox, A J Saah.   

Abstract

Cross-sectional studies have not adequately resolved the question of whether subjects infected with HIV-1 may suffer cognitive decline during the early, asymptomatic stages of the infection. We studied longitudinally 238 asymptomatic healthy HIV-1-infected homosexual/bisexual men (CDC groups 2 and 3) and 170 uninfected controls in the Multicenter AIDS Cohort Study with neuropsychological testing at semiannual intervals. A comparison of change in scores between visits 1 and 4 as well as a multivariate autoregressive analysis revealed no evidence of decline in test performance over time in the HIV-1-infected group compared with the seronegative controls. These findings suggest that a gradual cognitive decline does not occur during the early, asymptomatic stages of HIV infection.

Entities:  

Mesh:

Year:  1990        PMID: 2405290     DOI: 10.1212/wnl.40.2.204

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Feedback from the Sixth International AIDS Conference, San Francisco 1990.

Authors: 
Journal:  Genitourin Med       Date:  1991-04

Review 2.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

3.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.

Authors:  Valerie Wojna; Richard L Skolasky; Rosa Hechavarría; Rául Mayo; Ola Selnes; Justin C McArthur; Loyda M Meléndez; Elizabeth Maldonado; Carmen D Zorrilla; Hermes García; Edmundo Kraiselburd; Avindra Nath
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

4.  Cognitive function in early HIV infection.

Authors:  Aanchal Prakash; Jue Hou; Lei Liu; Yi Gao; Casey Kettering; Ann B Ragin
Journal:  J Neurovirol       Date:  2016-11-28       Impact factor: 2.643

5.  Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.

Authors:  G Villa; D Monteleone; C Marra; A Bartoli; A Antinori; F Pallavicini; E Tamburrini; I Izzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

6.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

7.  Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study.

Authors:  Quynh T Vo; Christopher Cox; Xiuhong Li; Lisa P Jacobson; Rosemary McKaig; Ned Sacktor; Ola A Selnes; Eileen Martin; James T Becker; Eric N Miller
Journal:  J Neurovirol       Date:  2012-12-11       Impact factor: 2.643

8.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

9.  Cognitive behavior in asymptomatic (CDC stage II and III) HIV--seropositive intravenous drug users (IVDUs).

Authors:  M Del Pesce; B Franciolini; B Censori; M Bartolini; F Ancarani; E Petrelli; L Provinciali
Journal:  Ital J Neurol Sci       Date:  1993-12

10.  Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort.

Authors:  H Manji; S Connolly; R McAllister; A R Valentine; B E Kendall; M Fell; P Durrance; A J Thompson; S Newman; I V Weller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.